Keyword: BioNTech


EMA’s CHMP Greenlights Omicron-1 Vaccines

06.09.2022 -

The human medicines committee (CHMP) of EU drug regulator European Medicines Agency (EMA) has recommended approval of the updated Covid-19 vaccines of Pfizer-BioNTech and...


FDA Grants EUAs to Omicron-targeted Covid Shots

02.09.2022 -

As had been widely expected, the US Food and Drug Administration (FDA) on Aug. 31 granted emergency use authorizations (EUAs) to the new Covid-19 shots developed by mRNA...


Moderna Says Pfizer and BioNTech Infringed Vaccine Patent

30.08.2022 -

BioNTech and Pfizer are facing another lawsuit claiming that their Comirnaty-branded Covid-19 vaccine infringes another company’s patent. The latest to sue is US rival...


Pfizer and BioNTech Counter CureVac Lawsuit

03.08.2022 -

Pfizer and BioNTech are fighting back against CureVac’s lawsuit that asserts the makers of the Comirnaty-branded mRNA vaccine for Covid-19 infringed its patent.


EMA Reviewing Pfizer/BioNTech Covid Shot for Youngest

19.07.2022 -

Pfizer and BioNTech have filed an application with the European Medicines Agency (EMA) for approval of the Comirnaty Covid-19 vaccine in children aged six months to five...


CureVac Sues BioNTech for IP Infringement

07.07.2022 -

Germany’s BioNTech is pushing back against allegations by compatriot CureVac that the company infringed its intellectual property in formulating its mRNA-based Covid-19...

Reserach & Innovation

New Covid Shots Score Points against Omicron

27.06.2022 -

Sanofi and GSK are touting their latecomer protein-based Covid-19 vaccine as a potential game changer in the fight against the Omicron variant.


FDA Panel Recommends Approval of Nuaxovid

09.06.2022 -

In a vote of 21 in favor with one abstention, the US Food and Drug Administration’s advisory panel has recommended that the FDA approve Novavax’s Covid-19 vaccine...